Evaluation of novel coagulation and platelet function assays in patients with chronic kidney disease.
Alyaa AbdelmaguidLara N RobertsLaura TugoresJennifer R JoslinBeverley Jane HuntKiran ParmarDanilo NebresSalah S NagaEman S KhalilKate BramhamPublished in: Journal of thrombosis and haemostasis : JTH (2022)
Patients with CKD exhibit features of concomitant hypercoagulability measured by ROTEM and platelet dysfunction measured with MEA. eGFR was an independent determinant of platelet dysfunction and hypercoagulability.